Regulatory B cells

Japanese Journal of Clinical Immunology

Volumn 32, Issue 3, 2009, Pages 135-141

  Yanaba, Koichi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Autoimmunity; B lymphocyte; IL 10; Inflammation

Indexed keywords

CD1D ANTIGEN; CD5 ANTIGEN; INTERLEUKIN 10;

ANTIBODY PRODUCTION; ARTHRITIS; AUTOIMMUNITY; B LYMPHOCYTE; CELLULAR DISTRIBUTION; COLITIS; CONTACT ALLERGY; ENCEPHALITIS; EXPERIMENTAL MOUSE; IMMUNOREGULATION; INFLAMMATORY DISEASE; LYMPHOCYTE SUBPOPULATION; NONHUMAN; NONOBESE DIABETIC MOUSE; OBESITY; REVIEW;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; DERMATITIS, ALLERGIC CONTACT; INFLAMMATION; INTERLEUKIN-10; MICE;

EID: 77953288709     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.32.135     Document Type: Review

References (23)

1. Yanaba, K. et al.: B-lymphocyte contributions to human autoimmune disease. Immunol. Rev. 223: 284-299, 2008.
2. + T cell activation in mice. Proc. Natl. Acad. Sci. USA. 104: 20882-20887, 2007.
3. Katz, S. I. et al.: B-cell suppression of delayed hypersensitivity reactions. Nature. 251: 550-551, 1974.
4. Wolf, S. D. et al.: Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278, 1996.
5. Mizoguchi, A. et al.: Suppressive role of B cells in chronic colitis of T cell receptor α mutant mice. J. Exp. Med. 186: 1749-1756, 1997.
6. Asadullah, K. et al.: Interleukin-10 therapy-review of a new approach. Pharmacol. Rev. 55: 241-269, 2003.
7. Fillatreau, S. et al.: B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950, 2002.
8. Mauri, C. et al.: Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501, 2003.
9. Mizoguchi, A. et al.: Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 16: 219-230, 2002.
10. Tian, J. et al.: Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167: 1081-1089, 2001.
11. Mizoguchi, A. et al.: A case for regulatory B cells. J. Immunol. 176: 705-710, 2006.
12. Bouaziz, J.D. et al.: Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 224: 201-214, 2008.
13. Fujimoto, M. et al.: B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity. J. Dermatol. Sci. 46: 1-9, 2007.
14. + phenotype controls T cell-dependent inflammatory responses. Immunity. 28: 639-650, 2008.
15. + type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165: 6783-6790, 2000.
16. Uchida, J. et al.: The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J. Exp. Med. 199: 1659-1669, 2004.
17. Krishnamoorthy, G. et al.: Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J. Clin. Invest. 116: 2385-2392, 2006.
18. Linington, C. et al.: Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130: 443-454, 1988.
19. Matsushita, T. et al.: Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118: 3420-3430, 2008.
20. Goetz, M. et al.: Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm. Bowel Dis. 13: 1365-1368, 2007.
21. Dass, S. et al.: Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum. 56: 2715-2718, 2007.
22. Hauser, S. L. et al.: B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358: 676-688, 2008.
23. Yanaba, K. et al.: The Development and Function of Regulatory B Cells Expressing IL-10 B10 Cells Requires Antigen Receptor Diversity and TLR Signals. J. Immunol. 182: In press, 2009.